Lab
Meriter Health Enterprises INC.
Meriter Health Enterprises INC. was paid $1.05M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 16% of everything it billed.
33Billing provider infoMERITER HEALTH ENTERPRISES INC.
MADISON, WI 53715
MADISON, WI 53715
33aNPI1346244993assigned 06/10/2005
33bProvider typeClinical Medical Laboratory
28Total paid$1.05M
24GClaims93,111
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Wisconsin
Rank by total paid#21 of 75
Median peer was paid$106K
This provider vs. median9.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,729 | $109K | |
| 2019 | 11,905 | $103K | |
| 2020 | 10,215 | $117K | |
| 2021 | 14,958 | $177K | |
| 2022 | 15,289 | $178K | |
| 2023 | 14,048 | $178K | |
| 2024incomplete | 14,967 | $184K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16% | 2,763 | 2,064 | $173K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.1% | 3,560 | 3,264 | $84K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.2% | 3,456 | 3,172 | $75K |
| 80053 | Comprehensive metabolic panel | 5.7% | 8,546 | 7,573 | $59K |
| 80061 | Lipid panel | 5.5% | 6,637 | 6,066 | $58K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.2% | 2,980 | 2,741 | $55K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.0% | 5,113 | 4,691 | $52K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.9% | 3,084 | 2,783 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.6% | 8,516 | 6,833 | $49K |
| 80050 | General health panel | 4.0% | 1,449 | 1,072 | $42K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.3% | 5,618 | 5,134 | $34K |
| 86803 | 2.7% | 2,632 | 2,431 | $28K |
64 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.4% | 259 | $25K |
| 86780 | 1.9% | 2,813 | $20K | |
| 82728 | 1.8% | 2,057 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 3,335 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 406 | $16K |
| 83970 | 1.3% | 360 | $14K | |
| 85027 | 1.3% | 3,003 | $14K | |
| 80074 | 1.2% | 352 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 2,338 | $12K |
| 82607 | <1% | 964 | $10K | |
| 81513 | <1% | 116 | $10K | |
| 84439 | <1% | 1,601 | $10K | |
| 87340 | <1% | 1,063 | $8K | |
| 82570 | <1% | 2,256 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 158 | $7K |
| 83550 | <1% | 1,022 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 54 | $5K |
| 83540 | <1% | 1,131 | $5K | |
| 86140 | <1% | 1,439 | $5K | |
| 82043 | <1% | 1,199 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 151 | $4K |
| 87631 | <1% | 40 | $4K | |
| 80076 | <1% | 609 | $4K | |
| 87481 | <1% | 116 | $3K | |
| 82746 | <1% | 286 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 193 | $3K |
| 87081 | <1% | 633 | $3K | |
| 87186 | <1% | 403 | $3K | |
| 84100 | <1% | 451 | $2K | |
| 86706 | <1% | 221 | $2K | |
| 83655 | <1% | 206 | $2K | |
| 84460 | <1% | 433 | $2K | |
| 86850 | <1% | 361 | $1K | |
| 85652 | <1% | 753 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 70 | $1K |
| 86762 | <1% | 112 | $1K | |
| 84403 | <1% | 86 | $1K | |
| 83735 | <1% | 226 | $1K | |
| 87070 | <1% | 170 | $1K | |
| 0240U | <1% | 49 | $1K | |
| 81015 | <1% | 559 | $1K | |
| 82947 | <1% | 411 | $1K | |
| 87150 | <1% | 58 | $1K | |
| 87210 | <1% | 282 | $991.69 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,424 | $944.51 |
| 86480 | <1% | 19 | $931.56 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 61 | $879.25 |
| 84450 | <1% | 244 | $866.00 | |
| 86769 | <1% | 51 | $853.10 | |
| 85018 | <1% | 364 | $853.06 | |
| 84153 | <1% | 55 | $625.07 | |
| 82565 | <1% | 132 | $474.68 | |
| 83690 | <1% | 108 | $413.91 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $393.14 |
| 82108 | <1% | 14 | $374.94 | |
| 87205 | <1% | 78 | $278.71 | |
| 87653 | <1% | 14 | $246.84 | |
| 86901 | <1% | 99 | $236.37 | |
| 86900 | <1% | 99 | $235.37 | |
| 84156 | <1% | 93 | $217.01 | |
| 86704 | <1% | 24 | $213.75 | |
| 81003 | <1% | 29 | $66.48 | |
| 85651 | <1% | 19 | $40.88 | |
| 86431 | <1% | 12 | $40.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialERDMAN, BETH (CFO)
| Provider | Location | Paid |
|---|---|---|
| Meriter Hospital, INC. | Madison, WI | $25.44M |
| Meriter Hospital, INC. | Madison, WI | $803K |
| Meriter Hospital, INC. | Madison, WI | $289K |
| Meriter Hospital, INC. | Madison, WI | $513.54 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.